tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of David Nierengarten, 311 are a BUY (82.71%), 63 are a HOLD (16.76%), 2 are a SELL (0.53%).
Analyst David Nierengarten, currently employed at WEDBUSH, carries an average stock price target met ratio of 42.29% that have a potential upside of 43.87% achieved within 199 days.
David Nierengarten’s has documented 827 price targets and ratings displayed on 64 stocks. The coverage is on Healthcare, Communication Services, Technology sectors.
Most recent stock forecast was given on IKNA, Ikena Oncology at 25-Jul-2025.
Analyst best performing recommendations are on SRRK (SCHOLAR ROCK HOLDING CORP).
The best stock recommendation documented was for SRRK (SCHOLAR ROCK HOLDING CORP) at 6/18/2018. The price target of $25 was fulfilled within 1 day with a profit of $3.57 (16.66%) receiving and performance score of 166.59.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$80
$53.06 (196.96%)
$42
4 days ago
(24-Jul-2025)
7/14 (50%)
$53.01 (196.41%)
545
Hold
$38
$11.06 (41.05%)
$22
1 months 24 days ago
(04-Jun-2025)
3/9 (33.33%)
$16.73 (78.66%)
44
Buy
$90
$63.06 (234.08%)
$54
2 months ago
(28-May-2025)
2/11 (18.18%)
$69.1 (330.62%)
229
Buy
$40
$13.06 (48.48%)
$42
5 months 21 days ago
(07-Feb-2025)
11/18 (61.11%)
$25.42 (174.35%)
108
Hold
$18
$-8.94 (-33.18%)
$33
7 months 15 days ago
(13-Dec-2024)
5/11 (45.45%)
$2.41 (15.46%)
109
Which stock is David Nierengarten is most bullish on?
Which stock is David Nierengarten is most reserved on?
What Year was the first public recommendation made by David Nierengarten?
